CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	3 Months Ended
	Sep. 30, 2023	Sep. 30, 2022
Cash flows from operating activities
Net loss from operations	$ (1,356,388)	$ (2,745,520)
Depreciation and amortization	1,472,905	924,406
Amortization of loan costs	15,137	49,158
Amortization of consideration discount	(108,955)	0
Change in deferred tax asset	0	(729,483)
Change in derivative liability	0	1,770
Stock based compensation	421,887	927,326
Changes in assets and liabilities, net of acquiried amounts
Accounts receivable	(2,435,858)	(180,525)
Inventory	(1,138,306)	(912,492)
Prepaid expenses and other assets	257,797	(681,964)
Accounts payable and accrued liabilities	690,004	969,770
Deferred revenue	19,819	0
Net cash used by operating activities - Continuing Operations	(2,120,290)	(2,516,787)
Net cash (used) provided by operating activities - Discontinued Operations	(223,957)	(4,240)
Net cash (used) provided by operating activities	(2,344,247)	(2,521,027)
Cash flows from investing activities
Proceeds from the sale of Interactive Offers, net of liabilities paid	147,592	0
Acquisition of Lucky Tail	0	(2,000,000)
Acquisition of VitaMedica, Inc., net of cash acquired	0	(500,000)
Acquisition of Cygnet, Inc., net of cash acquired	(500,000)	0
Acquisition of property and equipment	(296,313)	(147,930)
Net cash used in investing activities - Continuing Operations	(648,721)	(2,647,930)
Net cash used in investing activities - Discontinued Operations	0	0
Net cash used in investing activities	(648,721)	(2,647,930)
Cash flows from financing activities
Repayment of related party note payable	0	1,470,000
Payment of note payable	(317,371)	(152,186)
Change in line of credit, net	(764,844)	0
Net cash provided (used) by financing activities - Continuing Operations	(1,082,215)	1,317,814
Net cash provided by financing activities - Discontinued Operations	0	0
Net cash provided (used) by financing activities	(1,082,215)	1,317,814
Net decrease in cash - Continuing Operations	(3,851,226)	(3,846,903)
Net (decrease) increase in cash - Discontinued Operations	(223,957)	(4,240)
Cash, beginning of period	4,492,291	7,149,806
Cash, end of period	417,108	3,298,663
Supplemental cash flow disclosures
Interest paid	94,860	239,117
Income tax paid	0	0
Issuance of common stock for acquisition of Cygnet	162,727	0
Issuance of debt for the acquisition payable for Cygnet	$ 300,000	0
Bloomios non-cash payment of receivable, net	845,443
Stock issued for construction services for property and equipment	$ 0	$ 70,350